


{"id":53625,"date":"2024-12-08T01:59:08","date_gmt":"2024-12-07T23:59:08","guid":{"rendered":"https:\/\/www.fyb.de\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/"},"modified":"2024-12-11T01:59:08","modified_gmt":"2024-12-10T23:59:08","slug":"arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/","title":{"rendered":"ARQIS advises Medizintechnik Rostock on sale to SHS Capital"},"content":{"rendered":"<p>Rostock\/ T\u00fcbingen\/ D\u00fcssel\u00addorf \u2014 ARQIS has provi\u00added legal advice to the share\u00adhol\u00adders of Medi\u00adzin\u00adtech\u00adnik Rostock GmbH (MTR) on the sale of a majo\u00adrity stake to SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment mbH. SHS acqui\u00adres the share\u00adhol\u00adding for its sixth fund gene\u00adra\u00adtion (SHS IV) and thus secu\u00adres the corpo\u00adrate succes\u00adsion of MTR. The two previous share\u00adhol\u00adders and mana\u00adging direc\u00adtors of MTR will remain asso\u00adcia\u00adted with MTR through a signi\u00adfi\u00adcant share\u00adhol\u00adding. The parties invol\u00adved have agreed not to disc\u00adlose further details, such as the purchase price. Medi\u00adzin\u00adtech\u00adnik Rostock GmbH, with main loca\u00adti\u00adons in Rostock and Berlin, is a medium-sized company that supplies pati\u00adents with therapy devices for home use. MTR is one of the leading therapy and reha\u00adbi\u00adli\u00adta\u00adtion provi\u00adders and, as a part\u00adner of 80 health insu\u00adrance compa\u00adnies, carried out over 140,000 treat\u00adments in move\u00adment, elec\u00adtri\u00adcal and compres\u00adsion therapy in 2023. SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment mbH, based in T\u00fcbin\u00adgen, is a private equity fund that specia\u00adli\u00adzes in invest\u00adments in the health\u00adcare sector. SHS is curr\u00adently inves\u00adt\u00ading from its sixth fund, which was laun\u00adched in 2022 and has a volume of around 270 million euros. The share\u00adhol\u00adders and MTR have been advi\u00adsed on health\u00adcare law for many years by a team from D+B Rechts\u00adan\u00adw\u00e4lte Part\u00adner\u00adschaft mbB led by Dr. Ulrich Grau, who recom\u00admen\u00added ARQIS for this tran\u00adsac\u00adtion. The team led by Dr. J\u00f6rn-Chris\u00adtian Schulze then prevai\u00adled in a&nbsp;pitch.&nbsp;<\/p>\n<p><strong>Advi\u00adsor Medi\u00adzin\u00adtech\u00adnik Rostock GmbH: ARQIS (D\u00fcssel\u00addorf)<\/strong><\/p>\n<p>Dr. J\u00f6rn-Chris\u00adtian Schulze (Lead Part\u00adner), Seve\u00adrin Stef\u00adfens (Mana\u00adging Asso\u00adciate, both Tran\u00adsac\u00adtions), Part\u00adners: Thomas Chwa\u00adlek (Tran\u00adsac\u00adtions), Dr. Ulrich Lien\u00adhard (Real Estate), Marcus Noth\u00adhel\u00adfer (IP), Coun\u00adsel: Jens Knip\u00adping, Dennis Reisich (both Tax), Anja Mehr\u00adtens (HR Law), Mana\u00adging Asso\u00adcia\u00adtes: Tim Brese\u00admann, Diana Pucho\u00adwezki (both Real Estate), Daniel Schle\u00admann (Data Law), Nora Strat\u00admann (Commer\u00adcial), Rolf Tichy (IP), Martin Wein\u00adg\u00e4rt\u00adner (Pensi\u00adons), Asso\u00adcia\u00adtes: Rebecca Gester (Commer\u00adcial), Thomas Lipsky (IP), Jasmin Gr\u00fcnen (Tran\u00adsac\u00adtions), Sabine M\u00fcller, Dr. Hendrik V\u00f6lker\u00adding (both HR Law), Senior Legal Specia\u00adlist: Qing Xia (Tran\u00adsac\u00adtions) <strong>D+B (Berlin)<br>\n<\/strong><br>\n Dr. Ulrich Grau (lead), Nicole Jesche, Tatjana Teter\u00adju\u00adkow, Fran\u00adziska Dick\u00admann (all Health Law), Dr. Sabrina Neuen\u00addorf (Data Protec\u00adtion Law) <strong>About ARQIS<br>\n<\/strong><br>\n ARQIS is an inde\u00adpen\u00addent commer\u00adcial law firm opera\u00adting internationally.<\/p>\n<p> Around 80 lawy\u00aders and legal specia\u00adlists advise dome\u00adstic and foreign compa\u00adnies at the highest level on German, Euro\u00adpean and Japa\u00adnese commer\u00adcial law. With its focus groups Tran\u00adsac\u00adtions, HR Law, Japan, Data Law, Risk and Regu\u00adla\u00adtory, the firm is geared towards provi\u00adding its clients with compre\u00adhen\u00adsive advice. The law firm was foun\u00added in 2006 and has offices in D\u00fcssel\u00addorf, Munich and Tokyo as well as a talent hub in Berlin. http:\/\/www.arqis.com.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rostock\/ T\u00fcbingen\/ D\u00fcssel\u00addorf \u2014 ARQIS has provi\u00added legal advice to the share\u00adhol\u00adders of Medi\u00adzin\u00adtech\u00adnik Rostock GmbH (MTR) on the sale of a majo\u00adrity stake to SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment mbH. SHS acqui\u00adres the share\u00adhol\u00adding for its sixth fund gene\u00adra\u00adtion (SHS IV) and thus secu\u00adres the corpo\u00adrate succes\u00adsion of MTR. The two previous share\u00adhol\u00adders and managing&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":53627,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1368,1369,1372,1373],"tags":[],"class_list":["post-53625","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors","category-consultant","category-venture-capital-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ARQIS advises Medizintechnik Rostock on sale to SHS Capital - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"Rostock\/ - ARQIS has provided legal advice to the shareholders of Medizintechnik Rostock GmbH on the sale of a majority shareholding to SHS Gesellschaft f\u00fcr Beteiligungsmanagement mbH. SHS acquires the investment for its sixth fund generation (SHS IV) and thus secures the company succession of MTR. The two previous shareholders and managing directors of MTR will remain associated with MTR through a significant shareholding.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARQIS advises Medizintechnik Rostock on sale to SHS Capital - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Rostock\/ - ARQIS has provided legal advice to the shareholders of Medizintechnik Rostock GmbH on the sale of a majority shareholding to SHS Gesellschaft f\u00fcr Beteiligungsmanagement mbH. SHS acquires the investment for its sixth fund generation (SHS IV) and thus secures the company succession of MTR. The two previous shareholders and managing directors of MTR will remain associated with MTR through a significant shareholding.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-07T23:59:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-10T23:59:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"633\" \/>\n\t<meta property=\"og:image:height\" content=\"448\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"ARQIS advises Medizintechnik Rostock on sale to SHS Capital\",\"datePublished\":\"2024-12-07T23:59:08+00:00\",\"dateModified\":\"2024-12-10T23:59:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/\"},\"wordCount\":433,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis-1.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"Investors\",\"Consultant\",\"Venture Capital\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/\",\"url\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/\",\"name\":\"ARQIS advises Medizintechnik Rostock on sale to SHS Capital - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis-1.jpg\",\"datePublished\":\"2024-12-07T23:59:08+00:00\",\"dateModified\":\"2024-12-10T23:59:08+00:00\",\"description\":\"Rostock\/ - ARQIS has provided legal advice to the shareholders of Medizintechnik Rostock GmbH on the sale of a majority shareholding to SHS Gesellschaft f\u00fcr Beteiligungsmanagement mbH. SHS acquires the investment for its sixth fund generation (SHS IV) and thus secures the company succession of MTR. The two previous shareholders and managing directors of MTR will remain associated with MTR through a significant shareholding.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis-1.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis-1.jpg\",\"width\":633,\"height\":448},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARQIS advises Medizintechnik Rostock on sale to SHS Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ARQIS advises Medizintechnik Rostock on sale to SHS Capital - FYB Financial Yearbook","description":"Rostock\/ - ARQIS has provided legal advice to the shareholders of Medizintechnik Rostock GmbH on the sale of a majority shareholding to SHS Gesellschaft f\u00fcr Beteiligungsmanagement mbH. SHS acquires the investment for its sixth fund generation (SHS IV) and thus secures the company succession of MTR. The two previous shareholders and managing directors of MTR will remain associated with MTR through a significant shareholding.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/","og_locale":"en_US","og_type":"article","og_title":"ARQIS advises Medizintechnik Rostock on sale to SHS Capital - FYB Financial Yearbook","og_description":"Rostock\/ - ARQIS has provided legal advice to the shareholders of Medizintechnik Rostock GmbH on the sale of a majority shareholding to SHS Gesellschaft f\u00fcr Beteiligungsmanagement mbH. SHS acquires the investment for its sixth fund generation (SHS IV) and thus secures the company succession of MTR. The two previous shareholders and managing directors of MTR will remain associated with MTR through a significant shareholding.","og_url":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2024-12-07T23:59:08+00:00","article_modified_time":"2024-12-10T23:59:08+00:00","og_image":[{"width":633,"height":448,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"ARQIS advises Medizintechnik Rostock on sale to SHS Capital","datePublished":"2024-12-07T23:59:08+00:00","dateModified":"2024-12-10T23:59:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/"},"wordCount":433,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis-1.jpg","articleSection":["General","Featured","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","Investors","Consultant","Venture Capital"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/","url":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/","name":"ARQIS advises Medizintechnik Rostock on sale to SHS Capital - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis-1.jpg","datePublished":"2024-12-07T23:59:08+00:00","dateModified":"2024-12-10T23:59:08+00:00","description":"Rostock\/ - ARQIS has provided legal advice to the shareholders of Medizintechnik Rostock GmbH on the sale of a majority shareholding to SHS Gesellschaft f\u00fcr Beteiligungsmanagement mbH. SHS acquires the investment for its sixth fund generation (SHS IV) and thus secures the company succession of MTR. The two previous shareholders and managing directors of MTR will remain associated with MTR through a significant shareholding.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis-1.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/12\/dr-joern-christian-schulze-partner-bei-arqis-duesseldorf-foto-arqis-1.jpg","width":633,"height":448},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/arqis-advises-medizintechnik-rostock-on-sale-to-shs-capital\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"ARQIS advises Medizintechnik Rostock on sale to SHS Capital"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/53625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=53625"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/53625\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/53627"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=53625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=53625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=53625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}